Irinotecan and interstitial lung disease Patient Reports February 12, 2012

Irinotecan Side Effects Report #4830322-1
Irinotecan side effect was reported by a Physician from JAPAN on Nov 02, 2005. Male patient, 62 years of age, was diagnosed with rectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, malignant neoplasm progression, metastases to lung, rectal cancer, tumour marker increased. Irinotecan dosage: 60-100 MG (EVERY TWO WEEKS), INTRAVENOUS. During the same period patient was treated with TEGAFUR. Patient recovered.

Irinotecan Side Effects Report #5044548-8
Irinotecan side effect was reported by a Physician from JAPAN on June 16, 2006. Male patient, 76 years of age, weighting 119.0 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: contusion, depressed level of consciousness, head injury, interstitial lung disease, pulmonary oedema, road traffic accident, white blood cell count decreased. Irinotecan dosage: 220 MG (150 MG/M*2, IN 2 WEEKS), INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, GLYCYRRHIZA, MAGNESIUM OXIDE, BLOPRESS, AMLODIPINE. Patient recovered.

Irinotecan Side Effects Report #5045850-6
Irinotecan side effect was reported by a Physician from JAPAN on June 16, 2006. Male patient, 76 years of age, weighting 119.0 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: contusion, depressed level of consciousness, interstitial lung disease, road traffic accident. Irinotecan dosage: 220 MG (150 MG/M*2, IN 2 WEEKS), INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, GLYCYRRHIZA, MAGNESIUM OXIDE, BLOPRESS, AMLODIPINE. Patient recovered.

Irinotecan Side Effects Report #5269315-1
Irinotecan side effect was reported by a Health Professional from JAPAN on Feb 09, 2007. Male patient, 73 years of age, weighting 145.5 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, stomatitis. Irinotecan dosage: unknown. During the same period patient was treated with FLUOROURACIL, CALCIUM FOLINATE, CALCIUM FOLINATE, ALBUMIN TANNATE. Patient died on 02/09/2007.

Irinotecan Side Effects Report #4801721-9
Irinotecan side effect was reported by a Physician from JAPAN on Sept 29, 2005. Male patient, 70 years of age, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: decreased appetite, interstitial lung disease. Irinotecan dosage: 64 MG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE. Patient recovered.

Irinotecan Side Effects Report #5375368-2
Irinotecan side effect was reported by a Health Professional from JAPAN on June 18, 2007. Male patient, weighting 132.3 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, interstitial lung disease, thrombocytopenia. Irinotecan dosage: DAILY DOSE:120MG. During the same period patient was treated with TEGAFUR, LOXOPROFEN, GABEXATE MESILATE. Patient was hospitalized. Patient died.

Irinotecan Side Effects Report #4684741-7
Irinotecan side effect was reported by a Physician from on May 24, 2005. Female patient was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: aphagia, interstitial lung disease. Irinotecan dosage: 40 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with FURTULON. Patient died on 12/08/2004.

Irinotecan Side Effects Report #5107719-8
Irinotecan side effect was reported by a Physician from JAPAN on Aug 25, 2006. Male patient, 74 years of age, weighting 126.1 lb, was diagnosed with pleural mesothelioma malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphocyte stimulation test positive, pyrexia, respiratory failure. Irinotecan dosage: 60 MG (1 IN 7 D), INTRAVENOUS. During the same period patient was treated with METHOTREXATE, DOXORUBICIN. Patient recovered.

Irinotecan Side Effects Report #4844906-8
Irinotecan side effect was reported by a Physician from JAPAN on Nov 14, 2005. Male patient, 74 years of age, weighting 126.1 lb, was diagnosed with pleural mesothelioma malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Irinotecan dosage: unknown. During the same period patient was treated with METHOTREXATE, ADRIAMYCIN PFS. Patient recovered.

Irinotecan Side Effects Report #4823761-6
Irinotecan side effect was reported by a Physician from JAPAN on Oct 21, 2005. Male patient, 74 years of age, was diagnosed with pleural mesothelioma and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Irinotecan dosage: 60 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS. Patient recovered.

Irinotecan Side Effects Report #5256686-5
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on Feb 22, 2007. Female patient, weighting 116.8 lb, was diagnosed with ovarian cancer recurrent, interstitial lung disease, lymphangiosis carcinomatosa and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: diarrhoea, interstitial lung disease, intestinal perforation. Irinotecan dosage: unknown. During the same period patient was treated with PREDONINE, METHYLPREDNISOLONE SUCCINATE, METHYLPREDNISOLONE SUCCINATE, CISPLATIN. Patient recovered.

Irinotecan Side Effects Report #5072971-4
Irinotecan side effect was reported by a Physician from JAPAN on July 20, 2006. Female patient, 82 years of age, weighting 72.75 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, interstitial lung disease, leukopenia, lung infection, lymphangiosis carcinomatosa, malaise, malignant ascites, malignant neoplasm progression, pyrexia. Irinotecan dosage: 25 MG (1 IN 1 WK), INTRAVENOUS. During the same period patient was treated with LANSOPRAZOLE, JUZENTAIHOTO, ALLOID, FLUCALIN. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5033367-4
Irinotecan side effect was reported by a Physician from JAPAN on June 07, 2006. Female patient, 82 years of age, weighting 72.75 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, leukopenia, malignant neoplasm progression. Irinotecan dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, JUZENTAIHOTO, ALLOID, FLUCALIN. Patient recovered.

Irinotecan Side Effects Report #4693777-1
Irinotecan side effect was reported by a Physician from on June 03, 2005. Female patient, 68 years of age, weighting 81.57 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, bone marrow depression, condition aggravated, cyanosis, disease progression, disease recurrence, infection

, interstitial lung disease, malaise. Irinotecan dosage: unknown. During the same period patient was treated with GRAN, ETOPOSIDE, TAXOTERE. Patient was hospitalized. Patient died on 03/03/2005.

Irinotecan Side Effects Report #5117954-0
Irinotecan side effect was reported by a Physician from JAPAN on Sept 13, 2006. Female patient, 67 years of age, weighting 81.57 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, bone marrow failure, condition aggravated, infection

, interstitial lung disease, malaise, malnutrition, metastases to spleen. Irinotecan dosage: unknown. During the same period patient was treated with NEUPOGEN, ETOPOSIDE, TAXOTERE. Patient was hospitalized. Patient died on 03/03/2005.

Irinotecan Side Effects Report #4871100-7
Irinotecan side effect was reported by a Physician from JAPAN on Nov 26, 2005. Female patient, 56 years of age, weighting 113.8 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: chills, dyspnoea, eosinophil count increased, hypersensitivity, interstitial lung disease, neoplasm recurrence, ovarian cancer, pyrexia. Irinotecan dosage: 80 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with DOCETAXEL, WARFARIN, CEFOTIAM HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4871701-6
Irinotecan side effect was reported by a Physician from JAPAN on Nov 28, 2005. Female patient, 56 years of age, weighting 113.8 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 80 MG (INTERMITTENT) , INTRAVENOUS. During the same period patient was treated with DOCETAXEL, WARFARIN, CEFOTIAM HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4877490-3
Irinotecan side effect was reported by a Physician from JAPAN on Dec 26, 2005. Female patient, 56 years of age, weighting 113.8 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, chills, eosinophil count increased, hypersensitivity, injection site hypersensitivity, interstitial lung disease, lymphocyte count increased, ovarian cancer, pyrexia. Irinotecan dosage: 80 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with DOCETAXEL, WARFARIN, CEFOTIAM HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4911031-7
Irinotecan side effect was reported by a Physician from JAPAN on Jan 26, 2006. Female patient, 56 years of age, weighting 113.8 lb, was diagnosed with ovarian cancer, agranulocytosis and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, bronchoalveolar lavage abnormal, chills, computerised tomogram abnormal, dyspnoea, eosinophil count increased, hypersensitivity, interstitial lung disease, mycoplasma serology positive. Irinotecan dosage: 80 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with DOCETAXEL, WARFARIN, PANSPORIN. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4822569-5
Irinotecan side effect was reported by a Physician from JAPAN on Oct 19, 2005. Female patient was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: cell marker increased, computerised tomogram abnormal, dyspnoea, eosinophil count increased, hypersensitivity, interstitial lung disease, laboratory test abnormal, lymphocyte count increased, pyrexia. Irinotecan dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient recovered.

Irinotecan Side Effects Report #4704506-7
Irinotecan side effect was reported by a Consumer or non-health professional from on June 16, 2005. Male patient, 77 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, pneumonitis. Irinotecan dosage: 151 MG (INERVAL: DAYS 1, 8 EVERY 3 WEEKS), INTRAVNEOUS. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4726359-3
Irinotecan side effect was reported by a Physician from JAPAN on June 21, 2005. Male patient, 77 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: dyspnoea exertional, interstitial lung disease, pneumonitis. Irinotecan dosage: 151 MG (INTERVAL: DAYS 1, 8 EVERY 3 WEEKS),INTRAVENOUS. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4705710-4
Irinotecan side effect was reported by a Physician from on June 17, 2005. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, diffuse alveolar damage, interstitial lung disease, nasopharyngitis, pyrexia, rales. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died.

Irinotecan Side Effects Report #4934730-X
Irinotecan side effect was reported by a Physician from JAPAN on Feb 17, 2006. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, condition aggravated, diffuse alveolar damage, interstitial lung disease, nasopharyngitis. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died.

Irinotecan Side Effects Report #4661100-4
Irinotecan side effect was reported by a Health Professional from on Apr 28, 2005. Female patient, 70 years of age, weighting 137.6 lb, was diagnosed with non-small cell lung cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, blood lactate dehydrogenase increased, crepitations, diarrhoea, interstitial lung disease, nausea

. Irinotecan dosage: 152 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with GEMCITABINE HYDROCHLORIDE, LOSARTAN POTASSIUM, TRICHLORMETHIAZIDE, GLICLAZIDE, ACARBOSE, ATORVASTATIN CALCIUM, BUTENAFINE, ROHTO. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4934731-1
Irinotecan side effect was reported by a Physician from JAPAN on Dec 06, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer, ill-defined disorder and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: dyspnoea, eosinophil count increased, hypoxia, interstitial lung disease, leukopenia, lymphocyte count increased, pyrexia. Irinotecan dosage: 135 MG, CYCLICAL), INTRAVENOUS. During the same period patient was treated with TEGAFUR, NARTOGRASTIM, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5076620-0
Irinotecan side effect was reported by a Physician from JAPAN on July 24, 2006. Male patient, 48 years of age, weighting 165.3 lb, was diagnosed with non-small cell lung cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood ph increased, bone marrow failure, cold sweat, diarrhoea, infection

, interstitial lung disease, lung disorder, malignant pleural effusion. Irinotecan dosage: 115 MG/M2 (115 MG, 1 IN 1 WK), INTRAVENOUS. During the same period patient was treated with NEUTROGIN, CISPLATIN, INSULIN, BROCIN, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 05/25/2006.

Irinotecan Side Effects Report #5683261-0
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on Mar 12, 2008. Male patient, weighting 116.8 lb, was diagnosed with non-small cell lung cancer, hypertension, diarrhoea and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: alanine aminotransferase decreased, anorexia, aspartate aminotransferase decreased, blood potassium decreased, blood sodium decreased, interstitial lung disease, pneumonitis. Irinotecan dosage: DAILY DOSE:151MG-FREQ:INTERVAL: DAYS 1,8 EVERY 3 WEEKS. During the same period patient was treated with FRANDOL, URSO, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5765816-8
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on May 30, 2008. Female patient, weighting 137.6 lb, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus, hyperlipidaemia and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: DAILY DOSE:152MG-FREQ:INTERMITTENT. During the same period patient was treated with GEMZAR, NEO LOTAN, FLUITRAN, GLIMICRON, GLUCOBAY, LIPITOR, MENTAX, ROHTO. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5036622-7
Irinotecan side effect was reported by a Physician from JAPAN on June 09, 2006. Male patient was diagnosed with neoplasm malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: unknown. During the same period patient was treated with TEGAFUR. Patient recovered.

Irinotecan Side Effects Report #5042912-4
Irinotecan side effect was reported by a Physician from JAPAN on June 13, 2006. Male patient, weighting 138.5 lb, was diagnosed with neoplasm malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphangiosis carcinomatosa, malignant neoplasm progression, pneumonia

, pneumonia primary atypical. Irinotecan dosage: 100 MG/M*2 (100 MG/M*2), INTRAVENOUS. During the same period patient was treated with TEGAFUR, NORVASC. Patient recovered.

Irinotecan Side Effects Report #5056287-8
Irinotecan side effect was reported by a Physician from JAPAN on June 30, 2006. Male patient, 78 years of age, weighting 131.0 lb, was diagnosed with lung neoplasm malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: chills, electrocardiogram qrs complex prolonged, flushing, heart rate increased, hypoxia, interstitial lung disease, loss of consciousness, respiratory arrest, shock. Irinotecan dosage: 95 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, KYTRIL. Patient died on 06/29/2006.

Irinotecan Side Effects Report #5096737-4
Irinotecan side effect was reported by a Physician from JAPAN on June 30, 2006. Male patient, 78 years of age, weighting 131.0 lb, was diagnosed with lung neoplasm malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: electrocardiogram qrs complex prolonged, flushing, heart rate increased, hypoxia, infection

, interstitial lung disease, leukopenia, loss of consciousness, lymphangiosis carcinomatosa. Irinotecan dosage: 95 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with DECADRON, KYTRIL. Patient died on 06/29/2006.

Irinotecan Side Effects Report #4847589-6
Irinotecan side effect was reported by a Physician from JAPAN on Nov 22, 2005. Male patient, 63 years of age, was diagnosed with lung neoplasm malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: eosinophil count increased, interstitial lung disease. Irinotecan dosage: unknown. During the same period patient was treated with TEGAFUR. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5143214-8
Irinotecan side effect was reported by a Health Professional from JAPAN on Oct 16, 2006. Male patient, 64 years of age, was diagnosed with ill-defined disorder and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory failure, interstitial lung disease, leukopenia, neutropenia. Irinotecan dosage: (100 MG), INTRAVENOUS. During the same period patient was treated with NEDAPLATIN. Patient recovered.

Irinotecan Side Effects Report #4831655-5
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on Sept 27, 2005. Female patient, 64 years of age, was diagnosed with ill-defined disorder and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 120 MG, INTRAVENOUS. During the same period patient was treated with TEGAFUR, LOXOPROFEN. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4886852-X
Irinotecan side effect was reported by a Health Professional from JAPAN on Jan 06, 2006. Male patient, 64 years of age, was diagnosed with ill-defined disorder and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, pneumonitis. Irinotecan dosage: (100 MG), INTRAVENOUS. During the same period patient was treated with NEDAPLATIN. Patient recovered.

Irinotecan Side Effects Report #5079646-6
Irinotecan side effect was reported by a Physician from JAPAN on July 26, 2006. Male patient, 73 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acquired diaphragmatic eventration, anaemia, atelectasis, disease progression, hepatic failure, interstitial lung disease. Irinotecan dosage: unknown. During the same period patient was treated with FURTULON, URSO, GLYCYRON, DILTIAZEM HYDROCHLORIDE, NEUQUINON, ALDACTONE, LASIX. Patient recovered.

Irinotecan Side Effects Report #4847607-5
Irinotecan side effect was reported by a Physician from JAPAN on Nov 22, 2005. Male patient, 79 years of age, was diagnosed with gastric cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease. Irinotecan dosage: unknown. During the same period patient was treated with TEGAFUR, ALLEGRA, LIVOSTIN. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4850714-4
Irinotecan side effect was reported by a Physician from JAPAN on Nov 28, 2005. Male patient, 79 years of age, weighting 105.8 lb, was diagnosed with gastric cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 100 MG (INTERMITTENT) INTRAVENOUS. During the same period patient was treated with TEGAFUR, CHLORIDE, DEXAMETHASONE PHOSPHATE, ALLEGRA, LIVOSTIN, CELESTAMINE, MUCOSOLVAN. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4895952-X
Irinotecan side effect was reported by a Physician from JAPAN on Jan 12, 2006. Male patient, 79 years of age, weighting 105.8 lb, was diagnosed with gastric cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: unknown. During the same period patient was treated with TEGAFUR, CHLORIDE, DEXAMETHASONE PHOSPHATE, ALLEGRA, LIVOSTIN, CELESTAMINE. Patient was hospitalized. Patient died on 12/17/2005.

Irinotecan Side Effects Report #4556881-4
Irinotecan side effect was reported by a Physician from on Jan 07, 2005. Male patient, 37 years of age, weighting 174.2 lb, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, cardiac failure, infection

, interstitial lung disease, lymphangiosis carcinomatosa, nausea

, platelet count decreased, pulmonary oedema, white blood cell count decreased. Irinotecan dosage: 280 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with MITOMYCIN. Patient died on 03/08/2003.

Irinotecan Side Effects Report #4643026-5
Irinotecan side effect was reported by a Physician from on Apr 08, 2005. Male patient, 37 years of age, weighting 174.2 lb, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, blood beta-d-glucan increased, cardiac failure, cytomegalovirus antibody positive, interstitial lung disease, lymphangiosis carcinomatosa, nausea

, platelet count decreased, pleural effusion. Irinotecan dosage: 280 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with MITOMYCIN. Patient died on 03/08/2003.

Irinotecan Side Effects Report #4859979-6
Irinotecan side effect was reported by a Physician from JAPAN on Nov 07, 2005. Male patient, 75 years of age, weighting 132.3 lb, was diagnosed with gallbladder cancer

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, interstitial lung disease. Irinotecan dosage: 100 MG (1 IN 1 WEEK), INTRAVENOUS. During the same period patient was treated with GEMZAR. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4971587-5
Irinotecan side effect was reported by a Physician from JAPAN on Mar 24, 2006. Male patient, 75 years of age, weighting 132.3 lb, was diagnosed with gallbladder cancer

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: emphysema, gallbladder cancer

, interstitial lung disease, lymphangiosis carcinomatosa, malignant neoplasm progression, metastases to liver, platelet count increased. Irinotecan dosage: 100 MG (1 IN 1 WEEK); INTRAVENOUS. During the same period patient was treated with GEMZAR. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4805428-3
Irinotecan side effect was reported by a Physician from JAPAN on Oct 05, 2005. Male patient was diagnosed with gallbladder cancer

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: unknown. During the same period patient was treated with GEMZAR. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4603275-9
Irinotecan side effect was reported by a Physician from on Feb 24, 2005. Male patient, 70 years of age, was diagnosed with colorectal cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease. Irinotecan dosage: 120 MG/M2, INTRAVENOUS. During the same period patient was treated with TEGAFUR. Patient died on 09/05/2004.

Irinotecan Side Effects Report #4645749-0
Irinotecan side effect was reported by a Physician from on Apr 11, 2005. Male patient, 70 years of age, weighting 141.3 lb, was diagnosed with colorectal cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anorexia, condition aggravated, interstitial lung disease, nausea

, pelvic abscess. Irinotecan dosage: unknown. During the same period patient was treated with TEGAFUR URACIL, TEGAFUR GIMERACIL, TEGAFUR GIMERACIL. Patient died on 09/05/2004.

Irinotecan Side Effects Report #5206385-0
Irinotecan side effect was reported by a Pharmacist from JAPAN on Dec 28, 2006. Male patient, weighting 145.5 lb, was diagnosed with colorectal cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: DAILY DOSE:280MG. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE SOLUTION, IRINOTECAN HYDROCHLORIDE SOLUTION, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5207652-7
Irinotecan side effect was reported by a Pharmacist from JAPAN on Dec 28, 2006. Male patient, weighting 145.5 lb, was diagnosed with colorectal cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: DAILY DOSE:280MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5279450-X
Irinotecan side effect was reported by a Pharmacist from JAPAN on Mar 16, 2007. Male patient, weighting 145.5 lb, was diagnosed with colorectal cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, palpitations. Irinotecan dosage: DAILY DOSE:280MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5000038-X
Irinotecan side effect was reported by a Physician from JAPAN on Apr 03, 2006. Male patient, 77 years of age, was diagnosed with colorectal cancer

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 100 MG (100 MG, DAILY), INTRAVENOUS. During the same period patient was treated with TEGAFUR. Patient recovered.

Irinotecan Side Effects Report #4918148-1
Irinotecan side effect was reported by a Physician from JAPAN on Jan 31, 2006. Male patient, 75 years of age, weighting 103.6 lb, was diagnosed with colorectal cancer

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: candidiasis, diarrhoea, haemoglobin decreased, interstitial lung disease, leukopenia, neutropenia, thrombocytopenia. Irinotecan dosage: 180 MG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, RED BLOOD CELLS. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4967114-9
Irinotecan side effect was reported by a Health Professional from JAPAN on Dec 29, 2005. Female patient, 74 years of age, weighting 108.0 lb, was diagnosed with colorectal cancer

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, interstitial lung disease. Irinotecan dosage: unknown. During the same period patient was treated with TEGAFUR, LOPERAMIDE. Patient recovered.

Irinotecan Side Effects Report #4675299-7
Irinotecan side effect was reported by a Health Professional from on May 12, 2005. Male patient, 71 years of age, was diagnosed with colorectal cancer

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, interstitial lung disease, malignant pleural effusion, thrombocytopenia. Irinotecan dosage: unknown. During the same period patient was treated with FURTULON, COLONEL, HERBAL PREPARATION, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE. Patient died on 02/18/2005.

Irinotecan Side Effects Report #4618411-8
Irinotecan side effect was reported by a Health Professional from on Mar 10, 2005. Male patient, 70 years of age, was diagnosed with colorectal cancer

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 180 MG/INTERMITTENT, -INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient recovered.

Irinotecan Side Effects Report #4686741-X
Irinotecan side effect was reported by a Physician from on May 26, 2005. Male patient, 62 years of age, weighting 154.3 lb, was diagnosed with colorectal cancer

, hepatic cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 180 MG/INTERMITTENT,INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, DECADRON. Patient recovered.

Irinotecan Side Effects Report #4852365-4
Irinotecan side effect was reported by a Physician from JAPAN on Nov 29, 2005. Male patient, 61 years of age, was diagnosed with colorectal cancer

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: decreased appetite, interstitial lung disease, malaise, neutropenia. Irinotecan dosage: 100 MG (CYCLIC); INTRAVENOUS. During the same period patient was treated with ANTINEOPLASTIC AGENTS, ZANTAC, KYTRIL. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #6028049-6
Irinotecan side effect was reported by a Health Professional from SPAIN on Dec 15, 2008. Male patient, 68 years of age, was diagnosed with colon cancer stage iv and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: diffuse alveolar damage, interstitial lung disease, left ventricular hypertrophy, respiratory distress, respiratory failure. Irinotecan dosage: unknown. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient died.

Irinotecan Side Effects Report #6022337-5
Irinotecan side effect was reported by a Physician from SPAIN on Dec 15, 2008. Male patient, 68 years of age, was diagnosed with colon cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: disease progression, interstitial lung disease, metastases to lung, peripheral sensory neuropathy, respiratory distress, respiratory failure. Irinotecan dosage: unknown. During the same period patient was treated with OXALIPLATIN, FOLINIC ACID, FLUOROURACIL. Patient died.

Irinotecan Side Effects Report #6055996-1
Irinotecan side effect was reported by a Consumer or non-health professional from SPAIN on Jan 13, 2009. Male patient, 68 years of age, was diagnosed with colon cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: colon cancer metastatic, diffuse alveolar damage, disease progression, interstitial lung disease, left ventricular hypertrophy, malignant neoplasm progression, metastases to lung, myocardial ischaemia, neurotoxicity. Irinotecan dosage: unknown. During the same period patient was treated with OXALIPLATIN, FOLINIC ACID, FLUOROURACIL. Patient died.

Irinotecan Side Effects Report #5061728-6
Irinotecan side effect was reported by a Physician from JAPAN on July 04, 2006. Male patient, 82 years of age, was diagnosed with colon cancer, metastases to bone, metastases to liver, metastases to lung and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: candidiasis, catheter related infection, emphysema, interstitial lung disease, lymphangiosis carcinomatosa, malignant neoplasm progression, metastases to bone, metastasis, multi-organ failure. Irinotecan dosage: (100 MG, D1 AND D15, CYCLIC), INTRAVENOUS. During the same period patient was treated with MITOMYCIN, PIPERACILLIN. Patient died on 03/04/2003.

Irinotecan Side Effects Report #5056361-6
Irinotecan side effect was reported by a Physician from JAPAN on July 03, 2006. Male patient, 80 years of age, weighting 110.2 lb, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: diarrhoea, interstitial lung disease, leukopenia, pyrexia, vomiting. Irinotecan dosage: 100 MG/M2 (INTERMITTENT (100 MG)), INTRAVENOUS. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4999990-8
Irinotecan side effect was reported by a Physician from JAPAN on Apr 18, 2006. Male patient, 80 years of age, weighting 110.2 lb, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: diarrhoea, interstitial lung disease, leukopenia, neutropenia, pyrexia, vomiting. Irinotecan dosage: 100 MG/M2 (INTERMITTENT (100 MG)), INTRAVENOUS. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5030680-1
Irinotecan side effect was reported by a Physician from ITALY on June 05, 2006. Male patient, 74 years of age, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory failure, interstitial lung disease, liver disorder. Irinotecan dosage: 360 MG (CYCLIC), INTRAVENOUS. During the same period patient was treated with ERBITUX, FLUOROURACIL, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5288895-3
Irinotecan side effect was reported by a Physician from JAPAN on Mar 28, 2007. Female patient, 68 years of age, was diagnosed with colon cancer, constipation

, neuropathy peripheral, dyspepsia, gastritis, hiv infection

and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, leukopenia, neutropenia. Irinotecan dosage: DAILY DOSE:100MG. During the same period patient was treated with FLUOROURACIL, PURSENNID, VITAMEDIN S, MAGNESIUM OXIDE, SEVEN EP, CYANOCOBALAMIN, GASTER, EPIVIR. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5099781-6
Irinotecan side effect was reported by a Physician from JAPAN on Aug 10, 2006. Male patient, 67 years of age, weighting 138.5 lb, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: cell marker increased, interstitial lung disease, pneumonia fungal. Irinotecan dosage: unknown. During the same period patient was treated with TEGAFUR, NORVASC. Patient recovered.

Irinotecan Side Effects Report #4714859-1
Irinotecan side effect was reported by a Physician from FRANCE on June 29, 2005. Female patient, 65 years of age, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, liver disorder. Irinotecan dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient recovered.

Irinotecan Side Effects Report #4551799-5
Irinotecan side effect was reported by a Health Professional from on Dec 29, 2004. Female patient, 48 years of age, was diagnosed with cervix carcinoma and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 40 MG/M*2 INTERMITTENT, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4603087-6
Irinotecan side effect was reported by a Physician from on Feb 22, 2005. Male patient, 78 years of age, weighting 141.1 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, depressed level of consciousness, interstitial lung disease, pneumonitis, respiratory failure. Irinotecan dosage: 60 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient died on 01/16/2005.

Irinotecan Side Effects Report #4648778-6
Irinotecan side effect was reported by a Physician from on Apr 14, 2005. Male patient, 78 years of age, weighting 141.1 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, depressed level of consciousness, interstitial lung disease, lung neoplasm malignant, pneumonitis, refusal of treatment by patient, respiratory failure. Irinotecan dosage: 60 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with CISPLATIN, HERBAL PREPARATION. Patient died on 01/16/2005.

Irinotecan Side Effects Report #5022476-1
Irinotecan side effect was reported by a Physician from JAPAN on May 23, 2006. Male patient, 74 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: (70 MG,), INTRAVENOUS. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5177933-4
Irinotecan side effect was reported by a Pharmacist from JAPAN on Nov 27, 2006. Male patient, 70 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, palpitations, productive cough. Irinotecan dosage: 150 MG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, FAMOTIDINE, GASMOTIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5196948-3
Irinotecan side effect was reported by a Pharmacist from JAPAN on Dec 13, 2006. Male patient, 70 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease, palpitations, productive cough. Irinotecan dosage: 150 MG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, FAMOTIDINE, GASMOTIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #5097538-3
Irinotecan side effect was reported by a Physician from JAPAN on Aug 09, 2006. Male patient, 67 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 171 MG, SINGLE. During the same period patient was treated with ZOFRAN, DECADRON, PRIMPERAN, CLONAZEPAM, MUCOSTA, DEPAS, MAGNESIUM OXIDE, SALICYLAMIDE. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4546812-5
Irinotecan side effect was reported by a Consumer or non-health professional from on Dec 24, 2004. Male patient, 66 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 100 MG (1 CYCLICAL), INTRAVENOUS. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4718891-3
Irinotecan side effect was reported by a Physician from JAPAN on July 04, 2005. Male patient, 63 years of age, weighting 137.3 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease, metastases to adrenals. Irinotecan dosage: 100 MG, INTRAVENOUS. During the same period patient was treated with CISPLATIN, PREDNISONE. Patient was hospitalized. Patient recovered.

Irinotecan Side Effects Report #4690046-0
Irinotecan side effect was reported by a Physician from on May 31, 2005. Male patient, 62 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 100 MG, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient recovered.

Irinotecan Side Effects Report #4680065-2
Irinotecan side effect was reported by a Physician from on May 15, 2005. Male patient, 60 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 60 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient recovered.

Irinotecan Side Effects Report #4640680-9
Irinotecan side effect was reported by a Physician from on Apr 06, 2005. Male patient, 57 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 80 MG (DAY 1 + DAY 8). During the same period patient was treated with CARBOPLATIN. Patient recovered.

Irinotecan Side Effects Report #4680076-7
Irinotecan side effect was reported by a Physician from on May 15, 2005. Male patient, 57 years of age, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: 80 MG (DAY 1 + DAY 8), INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, NAPROXEN, DOMPERIDONE. Patient recovered.

Irinotecan Side Effects Report #5930030-X
Irinotecan side effect was reported by a Health Professional from JAPAN on Oct 14, 2008. Male patient was diagnosed with cerebral infarction, gastritis prophylaxis, radiation pneumonitis, cancer pain and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: interstitial lung disease. Irinotecan dosage: DAILY DOSE:180MG-FREQ:INTERMITTENT. During the same period patient was treated with ASPIRIN, RABEPRAZOLE, ALLEGRA, PREDNISOLONE, OXYCONTIN, OXINORM. Patient died on 04/02/2008.

Irinotecan and interstitial lung disease

SideEffects101.com

Irinotecan and interstitial lung disease Patient Reports February 12, 2012

side effects of Irinotecan